Aterian Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Net Revenue Annually69M
Gross Margin Quarterly5,680.0%
Operating Loss Annually-18MTarget: Breakeven
Watch Items
- Stockholder Approval of Marquee Brand Portfolio Asset SaleTrigger: Special Meeting Vote on July 10, 2026Action: Monitor proxy voting results and subsequent cash distribution of $0.85 to $1.14 per share expected in Q3 2026.
- Strategic Preferred Stock Financing and Preferred Stock ConversionsTrigger: Closing of $7.0 million preferred stock investment from David E. LazarAction: Evaluate dilution risk from preferred stock conversions and monitor the implementation of the reverse stock split (range 1-for-2 to 1-for-99).
Research as of 20 Jun 2026